Alvaro Ruibal Morell-rekin lankidetzan egindako argitalpenak (12)

1992

  1. Serum prolactin levels in women with gross cystic breast disease

    International Journal of Biological Markers, Vol. 7, Núm. 4, pp. 225-229

1991

  1. Comportamiento del factor de crecimiento epidérmico en el líquido de los quistes mamarios. Diferencias en función de los tres tipos existentes.

    Revista Clinica Espanola

  2. Correlación entre las concentraciones séricas de BCM (mucina del cáncer de mama), CA549 y estradiol en mujeres afectas de macroquistes mamarios.

    Medicina Clinica

  3. Evidence of a correlation between CA 15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease [1]

    International Journal of Biological Markers

  4. GCDFP-70 protein in cyst fluid identified as albumin and used to classify cysts in women with breast gross cystic disease

    Clinical Chemistry, Vol. 37, Núm. 4, pp. 547-551

1990

  1. Correlación entre las concentraciones séricas de CA 549 y CA 15,3 en pacientes afectas de enfermedad quística mamaria.

    Revista Clinica Espanola

  2. Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast disease

    International Journal of Biological Markers

  3. Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytologic examination

    European Journal of Surgical Oncology, Vol. 16, Núm. 3, pp. 209-214

  4. High BCM serum levels in patients with non breast tumors: First results

    Bulletin du Cancer

  5. Niveles de estriol en el líquido quístico de mujeres afectas de enfermedad quística mamaria.

    Revista clinica espanola

  6. Serum BCM levels in patients with non-tumoral pathologies: A value of 25 U/ml can be used as threshold for tumoral activity

    International Journal of Biological Markers

1989

  1. CA 15.3 behaviour in cystic breast disease.

    International Journal of Biological Markers